Concepedia

Rui Zeng

RZ

Statistics

Publications

8

Citations

845

H-Index

8

Active since

2011

Affiliations

Sichuan University(Current)

Chinese Academy of Sciences

University of Hong Kong

Kunming Institute of Zoology

West China Hospital of Sichuan University

Rui Zeng is an author at Sichuan University specializing in sars-cov-2 infection, pharmacology, and molecular virology.

ORCID

Publications per year

2011–2023

8

Publications

8

SARS-CoV-2 M <sup>pro</sup> inhibitors with antiviral activity in a transgenic mouse model

Jingxin Qiao, Yueshan Li, Rui Zeng et al. · Science · 2021 · 450 citations · Full text

, , +15

Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein

Renjie Zhou, Rui Zeng, Albrecht von Brunn et al. · Molecular Biomedicine · 2020 · 121 citations · Full text

, , +17

An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron

Baoxue Quan, Huiping Shuai, Anjie Xia et al. · Nature Microbiology · 2022 · 101 citations · Full text

, , +8

A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants

Chong Huang, Huiping Shuai, Jingxin Qiao et al. · Signal Transduction and Targeted Therapy · 2023 · 81 citations · Full text

, , +15

GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer

Jinhua Wu, Na Xie, Ke Xie et al. · Carcinogenesis · 2013 · 45 citations · Full text

, , +17

1–5 of 8